Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF-Reference-Cited by-同舟云学术

Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF

Published:2006-01 Issue:2 Volume:281 Page:951-961
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Liang Wei-Ching,Wu Xiumin,Peale Franklin V.,Lee Chingwei V.,Meng Y. Gloria,Gutierrez Johnny,Fu Ling,Malik Ajay K.,Gerber Hans-Peter,Ferrara Napoleone,Fuh Germaine

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference44 articles.

1. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

2. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

3. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models

4. Vascular-specific growth factors and blood vessel formation

Cited by 313 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Milestones in tumor vascularization and its therapeutic targeting;Nature Cancer;2024-06-25

2. Myopiekontrolle bei Kindern: Effektivität von Brillengläsern mit asphärischen Mikrolinsen nach 3 Jahren;Klinische Monatsblätter für Augenheilkunde;2024-02

3. Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy;Journal of Hematology & Oncology;2023-08-12

4. Computational optimization of antibody humanness and stability by systematic energy-based ranking;Nature Biomedical Engineering;2023-08-07

5. FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy;Cell Reports;2023-08